Limbrel Capsules by Primus Pharmaceuticals: FDA Advisory – Linked to Potentially Life-Threatening Health Problems

In total, the FDA has received 194 adverse event reports regarding Limbrel, of those, 57 of the cases contained sufficient information to analyze in detail whether Limbrel was associated with an adverse event; 30 of these contained sufficient information to use the Council for International Organizations of Medical Sciences (CIOMS) causality assessment method to determine the likelihood that an association between the consumption of Limbrel and the adverse events reported exists.

[...]

The ‘Price Savings’ of Drug Importation— Unboxing the Myth

Wayne Winegarden and Nouran Ghana’s editorial was published in Inside Sources on November 15, 2017. In it, they take a hard look at the supposed “price savings” of drug importation and find that the promises do not live up to what would happen. They believe that Americans deserve a better solution than plundering the drug supply of a neighboring country…

[...]

Reauthorization of Generic Drug User Fee Seen As A Win For Consumers

Starting in 2012, the Generic Drug User Fee Amendments helped increase the number of generic drug applications approved by the FDA. Having recently been reauthorized, the FDA looks forward to increasing the number of safe and affordable generic drugs available to American citizens…

[...]